Protein unfolding in a physiological system
蛋白质在生理系统中的展开
基本信息
- 批准号:6876178
- 负责人:
- 金额:$ 30.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:Saccharomyces cerevisiaeautoradiographybacterial proteinscell free systemchemical stabilitycomputer simulationdihydrofolate reductaseelectrochemistryheat shock proteinsintermolecular interactionintracellular transportmembrane potentialsmitochondriamitochondrial membranemolecular chaperonesmolecular sitenuclear magnetic resonance spectroscopyphosphodiesterasesprotein biosynthesisprotein foldingprotein signal sequenceprotein structure functionprotein transportradiotracerthermodynamics
项目摘要
Description (provided by applicant): Regulated unfolding is critically
important in the lifecycle of many proteins, such as those translocated across
mitochondrial and chloroplast membranes, as well as those degraded by
ATP-dependent proteases such as the proteasome. About half of all proteins
synthesized in the eukaryotic cell are transported into or across a membrane.
The protein translocation machineries are well defined biologically, but the
means by which they transport and unfold proteins are not well understood at
the biochemical and biophysical level. In contrast to protein folding, the
mechanism of protein unfolding in the living cell has not been studied
previously.
The aims of this proposal are to understand the structural changes that occur
in the unfolding protein prior to translocation and the molecular mechanisms of
the unfolding machinery. The pathways of unfolding for a range of model
proteins that translocate across membranes will be determined and compared with
the pathway of spontaneous unfolding in solution. The mechanism of the
unfoldase will be determined by inhibiting candidates either chemically or by
mutation and measuring the effect on unfolding. The components of the import
machinery that contribute to unfolding will be identified and the way in which
they interact with each other the substrate protein determined. The hypothesis
that the machinery unravels proteins by a physical pulling mechanism will be
tested.
This information is necessary to understand protein unfolding processes in the
cell and to understand the function of a complex protein machine. The
conclusions will also have broad implications for the understanding of protein
translocation processes in the cell, in particular on the mechanisms that
provide specificity to protein targeting to membranes. Interestingly, the
unfolding processes during translocation and degradation share mechanistic
features. Finally, the subject is directly relevant to human diseases. For
example, an inherited form of oxalosis is due to the miss-sorting of an enzyme
from peroxisomes to mitochondria. Since unfolding is not required for import
into peroxisomes and the miss-sorted protein contains functional peroxisomal
targeting information, preventing unfolding should correct the sorting defect.
描述(由申请人提供):调节性解折叠是关键性的
在许多蛋白质的生命周期中很重要,例如那些跨
线粒体和叶绿体膜,以及那些降解的
ATP依赖性蛋白酶,如蛋白酶体。大约一半的蛋白质
在真核细胞中合成的蛋白质被转运进入或穿过膜。
蛋白质易位机制在生物学上是明确的,但
它们运输和展开蛋白质的方式尚不清楚,
生物化学和生物物理水平。与蛋白质折叠相反,
蛋白质在活细胞中的解折叠机制尚未被研究
以前。
本提案的目的是了解发生的结构性变化,
在易位前的解折叠蛋白中,
展开的机器一系列模型的解折叠路径
跨膜转运的蛋白质将被确定并与
在溶液中自发展开的途径。的机理
解折叠酶将通过化学地或通过
突变和测量对展开的影响。进口的组成部分
将确定有助于展开的机制,以及
它们相互作用的底物蛋白质确定。的假设
这台机器通过物理拉动机制分解蛋白质,
测试.
这些信息对于理解蛋白质在细胞中的解折叠过程是必要的。
细胞和理解复杂蛋白质机器的功能。的
这些结论也将对理解蛋白质
在细胞中的易位过程,特别是对机制,
为蛋白质靶向膜提供特异性。有趣的是
在易位和降解过程中的解折叠过程共享机制
功能.最后,这一主题与人类疾病直接相关。为
例如,一种遗传形式的草酸盐中毒是由于一种酶的错误分选
从过氧化物酶体到线粒体。由于导入不需要展开
错误分选的蛋白质含有功能性过氧化物酶体
瞄准信息,防止展开应纠正排序缺陷。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREAS MATOUSCHEK其他文献
ANDREAS MATOUSCHEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREAS MATOUSCHEK', 18)}}的其他基金
Development of proteasome adaptors to catalytically deplete specific proteins from cells
开发蛋白酶体接头以催化消耗细胞中的特定蛋白质
- 批准号:
9253359 - 财政年份:2016
- 资助金额:
$ 30.5万 - 项目类别:
Encoding and Interpreting Information at the Protein Level
在蛋白质水平上编码和解释信息
- 批准号:
7820275 - 财政年份:2009
- 资助金额:
$ 30.5万 - 项目类别:
相似海外基金
Harnessing PET to Study the In Vivo Fate and Health Effects of Micro- and Nanoplastics
利用 PET 研究微塑料和纳米塑料的体内命运和健康影响
- 批准号:
10890903 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
- 批准号:
10576674 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Altered microglia states and microglia-endothelial cell axis in relation to white matter disease progression in VCID
VCID 中小胶质细胞状态和小胶质细胞内皮细胞轴的改变与白质疾病进展相关
- 批准号:
10738860 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
- 批准号:
10637434 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Assessing Diffusion MRI Metrics for Detecting Changes of Synaptic Density in Alzheimer's Disease
评估弥散 MRI 指标以检测阿尔茨海默病突触密度的变化
- 批准号:
10739911 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
- 批准号:
10829189 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Probing D2 and 5HT-2A mechanisms in early visual processing in V1
探索 V1 早期视觉处理中的 D2 和 5HT-2A 机制
- 批准号:
10605769 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Develop in vivo PET imaging probes for ROCK2 as a biomarker of early Alzheimer's disease.
开发 ROCK2 的体内 PET 成像探针作为早期阿尔茨海默病的生物标志物。
- 批准号:
489145 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Operating Grants